Medication
Erythromycin Ophthalmic Ointment Usp
DIN 02326663 · Steri-Med Pharma Inc. Likely a generic
What it is
- Active ingredients
- Erythromycin — 5 mg
- Form and route
- Ointment · Ophthalmic
- Schedule
- PRESCRIPTION
- Authorised since
- 2010-02-12
Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.
Products with the same active ingredient
No other medication authorised in Canada shares this active ingredient.
Health Canada groups products by their active ingredients. No other marketed product shares this one’s group, which usually means it is still the only authorised version — not that alternatives were hidden or missed.
Watch this medication
Ontario Drug Benefit coverage
As of 31 July 2026This medication is not listed on the Ontario Drug Benefit formulary.
Not on the formulary is not the same as not covered. Private and workplace insurance, federal programs such as Non-Insured Health Benefits and Veterans Affairs, and every other province’s public plan are all outside what this page shows — Ontario is the only province RxMonitor holds coverage data for. Ontario may also fund a product that is not on the formulary through the Exceptional Access Program.
Source: Ontario Ministry of Health — ODB Formulary. Data current as of 2026-07-28. Ontario only. Formulary edition 4342, effective 31 July 2026.
How it is classified
- Anatomical main group
- Sensory organs
- ATC code
- S01AA17
The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of S01AA17, see the WHO ATC/DDD Index.
Recalls and safety alerts
As of 12 August 2026Health Canada has published 3 recalls or safety alerts naming this product. Read them on Health Canada’s own site, and speak to a pharmacist before changing anything about how you take this medication.
ERYTHROMYCIN OPHTHALMIC OINTMENT USP: The sterility of the product could be compromised.
Health Canada says: Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns. Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada.
Matched on the product name in the notice.
ERYTHROMYCIN OPHTHALMIC OINTMENT USP: Product sterility may be compromised
Health Canada says: Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns. Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada.
Matched on the product name in the notice.
ERYTHROMYCIN OPHTHALMIC OINTMENT USP: Sterility Concerns
Health Canada says: Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada.
Matched on the product name in the notice.
This list may be incomplete. Health Canada’s recalls data carries no DIN, so notices are matched on wording alone. Search Health Canada recalls for Erythromycin Ophthalmic Ointment Usp → How RxMonitor matches recalls, and how often it fails
Source: Health Canada — Recalls and Safety Alerts. Data current as of 2026-08-12. Matched on product name, not on DIN — the feed carries none.